CONSEQUENCES OF ABRUPT DISCONTINUATION OF ANTI TUBERCULAR THERAPY (ATT) DUE TO ADVERSE DRUG REACTION (ADRS): A TERTIARY HOSPITAL BASED STUDY. PharmaNexus Bull. 2026;2(2):1-5. Accessed August 27, 2026. https://lapinjournals.com/index.php/pnb/article/view/208